Elevance Health Inc. (ELV)
NYSE: ELV
· Real-Time Price · USD
312.52
3.20 (1.03%)
At close: Aug 19, 2025, 3:59 PM
313.60
0.35%
After-hours: Aug 19, 2025, 06:19 PM EDT
Elevance Health Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
| Carelon Services Segment Revenue | 53.92B | 95.96B |
| Carelon Services Segment Revenue Growth | -43.81% | n/a |
| Health Benefits Segment Revenue | 150.28B | 148.57B |
| Health Benefits Segment Revenue Growth | +1.15% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.82B | 4.8B | 4.56B | 4.51B | 4.27B | 4.34B | 4.22B | 3.95B | 3.82B | 3.92B | 4.32B | 5.3B | 4.05B | 3.78B | 3.5B | 3.42B | 3.28B | 3.17B | 3.62B | 3.55B | 3.43B | 3.43B | 3.39B | 3.01B | 3.05B | 3.19B | 3.26B | 3.12B | 2.97B | 3.2B | 3.27B | 3.08B | 3.04B | 3.15B |
| Selling, General, and Administrative Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | +0.38% | +5.22% | +1.06% | +5.66% | -1.68% | +2.91% | +6.99% | +3.27% | -2.65% | -9.10% | -18.61% | +31.12% | +7.01% | +7.97% | +2.46% | +4.27% | +3.54% | -12.49% | +2.03% | +3.44% | 0.00% | +1.02% | +12.70% | -1.40% | -4.31% | -2.23% | +4.46% | +5.24% | -7.22% | -2.09% | +6.10% | +1.30% | -3.32% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |